Profile
Full Name
Karyopharm Therapeutics Inc.Ticker
NASDAQ: KPTIExchange
NASDAQSector
HealthcareIndustry
BiotechnologyCountry
United StatesIPO
November 6, 2013Indexes
Not includedWebsite
http://www.karyopharm.comEmployees
279Key Details
Price
$4.43(-8.85%)
Market cap
$38.27M(Small cap)
Last Dividend
-
TTM Dividend yield
-
Annual revenue
$145.24M(-0.55% YoY)
Annual EPS
-$13.95(+25.60% YoY)
PE ratio
-
Next earnings date
Aug 6, 2025Next ex-dividend date
N/ANext split date
N/AQuick Search
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Analyst ratings
Price
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Price Performance
Price Range
Capitalization
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Market cap
Shares Outstanding
Technical Indicators
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
Karyopharm Therapeutics Inc. doesn't have historical dividend data
Income Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Revenue
EPS
Profit
Expenses
EBIT & EBITDA
Balance Sheet
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Assets
Liabilities
Debt
Equity & Capital
Cash Flow Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cashflow Activities
CAPEX
Free Cash Flow
Profitability Ratios
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Margins
ROA & ROE
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Leverage
Risk & Stability
Analyst ratings
Recent major analysts updates
Jul 16, 25 HC Wainwright & Co.
NeutralMay 13, 25 RBC Capital
OutperformMay 13, 25 Barclays
OverweightMay 13, 25 Baird
OutperformMar 3, 25 Baird
OutperformFeb 26, 25 HC Wainwright & Co.
BuyFeb 20, 25 RBC Capital
OutperformFeb 20, 25 HC Wainwright & Co.
BuyFeb 10, 25 RBC Capital
OutperformJan 15, 25 HC Wainwright & Co.
BuyInstitutional Ownership
- What is the ticker symbol for Karyopharm Therapeutics Inc.?
- Does Karyopharm Therapeutics Inc. pay dividends?
- What sector is Karyopharm Therapeutics Inc. in?
- What industry is Karyopharm Therapeutics Inc. in?
- What country is Karyopharm Therapeutics Inc. based in?
- When did Karyopharm Therapeutics Inc. go public?
- Is Karyopharm Therapeutics Inc. in the S&P 500?
- Is Karyopharm Therapeutics Inc. in the NASDAQ 100?
- Is Karyopharm Therapeutics Inc. in the Dow Jones?
- When was Karyopharm Therapeutics Inc.'s last earnings report?
- When does Karyopharm Therapeutics Inc. report earnings?
What is the ticker symbol for Karyopharm Therapeutics Inc.?
The ticker symbol for Karyopharm Therapeutics Inc. is NASDAQ:KPTI
Does Karyopharm Therapeutics Inc. pay dividends?
No, Karyopharm Therapeutics Inc. does not pay dividends
What sector is Karyopharm Therapeutics Inc. in?
Karyopharm Therapeutics Inc. is in the Healthcare sector
What industry is Karyopharm Therapeutics Inc. in?
Karyopharm Therapeutics Inc. is in the Biotechnology industry
What country is Karyopharm Therapeutics Inc. based in?
Karyopharm Therapeutics Inc. is headquartered in United States
When did Karyopharm Therapeutics Inc. go public?
Karyopharm Therapeutics Inc.'s initial public offering (IPO) was on November 6, 2013
Is Karyopharm Therapeutics Inc. in the S&P 500?
No, Karyopharm Therapeutics Inc. is not included in the S&P 500 index
Is Karyopharm Therapeutics Inc. in the NASDAQ 100?
No, Karyopharm Therapeutics Inc. is not included in the NASDAQ 100 index
Is Karyopharm Therapeutics Inc. in the Dow Jones?
No, Karyopharm Therapeutics Inc. is not included in the Dow Jones index
When was Karyopharm Therapeutics Inc.'s last earnings report?
Karyopharm Therapeutics Inc.'s most recent earnings report was on May 12, 2025
When does Karyopharm Therapeutics Inc. report earnings?
The next expected earnings date for Karyopharm Therapeutics Inc. is August 6, 2025